Can N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) reliably rule out heart failure in a patient with grade 1 diastolic dysfunction, E/A ratio 0.69, left atrial volume index 21.1 mL/m², E/e′ 9.2 (rising), mild bilateral pitting edema attributed to venous insufficiency, and suspected heart‑failure‑with‑preserved‑ejection‑fraction (HFpEF) physiology?

NT-proBNP Has Excellent Utility for Ruling Out Heart Failure in Your Case

NT-proBNP testing can reliably exclude clinically significant heart failure in your situation, given your grade 1 diastolic dysfunction, normal left atrial volume, and borderline E/e' ratio. A value below 300 pg/mL would effectively rule out heart failure with 98–99% negative predictive value, while a value above 900 pg/mL (age-adjusted for your 73 years) would strongly suggest the syndrome has developed. 1, 2

Understanding Your Current Cardiac Status

Your echocardiographic findings represent HFpEF physiology without the syndrome—meaning you have the structural substrate (grade 1 diastolic dysfunction) but lack sufficient clinical evidence to diagnose heart failure as a disease entity. 1 The key distinction is:

• Grade 1 diastolic dysfunction (E/A ratio 0.69) indicates impaired relaxation but is the mildest form of diastolic abnormality 1
• Normal left atrial volume index (21.1 mL/m²; normal <34 mL/m²) argues strongly against chronic elevated filling pressures 1
• E/e' of 9.2 sits just below the threshold of 10 that suggests elevated filling pressures, though you note it is rising 1
• Bilateral ankle edema is fully explained by venous insufficiency, not cardiac congestion 1

How NT-proBNP Performs in Your Specific Scenario

Ruling Out Heart Failure (The Primary Strength)

NT-proBNP excels at excluding heart failure rather than confirming it. 1, 2 In your case:

• NT-proBNP <300 pg/mL would effectively rule out clinically significant heart failure with 98–99% certainty, making further cardiac work-up unnecessary 1, 2
• This threshold maintains its excellent negative predictive value even in patients with mild diastolic dysfunction 1, 2
• The test is specifically designed to answer the question: "Does this patient's symptom (edema) represent heart failure?" 1

The Gray Zone (300–900 pg/mL)

If your NT-proBNP falls between 300–900 pg/mL, interpretation becomes more nuanced:

• This range has only 60–76% specificity for heart failure, requiring integration of clinical context 1, 2
• Given your normal left atrial volume and only grade 1 diastolic dysfunction, values in this range would more likely reflect your rising E/e' trend rather than established HFpEF syndrome 1, 3
• You would need confirmatory stress testing or invasive hemodynamic assessment to establish whether elevated filling pressures develop with exertion 1

Values Above 900 pg/mL (Age-Adjusted Threshold)

For a 73-year-old patient, NT-proBNP >900 pg/mL strongly indicates clinically significant heart failure (positive likelihood ratio >10): 1, 2

• This would suggest your HFpEF physiology has progressed to HFpEF syndrome 1
• It would warrant initiation of guideline-directed therapy (loop diuretics, blood pressure optimization, comorbidity management) 1, 2
• However, this seems unlikely given your normal left atrial volume and mild diastolic dysfunction 1, 3

Critical Adjustments for Your Specific Situation

Venous Insufficiency Does Not Confound NT-proBNP

Your diagnosed venous insufficiency is a peripheral vascular problem that does not elevate NT-proBNP—the biomarker responds specifically to myocardial wall stress, not peripheral edema from venous stasis. 2, 4 This makes NT-proBNP particularly valuable in your case to differentiate cardiac from non-cardiac edema.

Factors That Could Affect Your Result

You should be aware of conditions that might alter NT-proBNP interpretation:

• Obesity (BMI ≥30 kg/m²) lowers NT-proBNP by 20–30%, potentially masking cardiac dysfunction; if you are obese, reduce diagnostic thresholds by 20–30% 2, 4
• Chronic kidney disease (eGFR <60 mL/min/1.73 m²) raises NT-proBNP independent of cardiac status; if your creatinine is elevated, the rule-out threshold increases to 1,200 pg/mL 1, 2
• Atrial fibrillation independently elevates NT-proBNP by 20–30%; if you have AF, higher thresholds apply 1, 2
• Age >75 years increases baseline NT-proBNP, though at 73 you use the 50–75 year threshold of 900 pg/mL 1, 2

What NT-proBNP Cannot Tell You

NT-proBNP cannot distinguish between systolic and diastolic heart failure—it only indicates myocardial wall stress. 4, 3 Your echocardiogram already established preserved ejection fraction, so NT-proBNP adds value by determining whether your diastolic dysfunction has progressed to cause clinically significant heart failure. 1, 3

NT-proBNP levels are consistently lower in HFpEF than HFrEF for the same degree of symptoms, because preserved ejection fraction generates less wall stress despite elevated filling pressures. 3, 5 Up to one-third of HFpEF patients have normal BNP levels despite elevated filling pressures on invasive testing. 3, 5 This means:

• A low NT-proBNP strongly argues against HFpEF syndrome 1, 2
• A mildly elevated NT-proBNP (300–900 pg/mL) in your context might reflect early HFpEF physiology progressing toward syndrome, but is not diagnostic 1, 3
• Only values >900 pg/mL would definitively indicate HFpEF syndrome in your age group 1, 2

Practical Recommendation for Your Case

Order NT-proBNP to definitively rule out heart failure as the cause of your edema. 1, 2 The test should be interpreted as follows:

1. <300 pg/mL: Heart failure effectively excluded; attribute edema entirely to venous insufficiency and focus on compression therapy, leg elevation, and venous management 1, 2

2. 300–900 pg/mL: Gray zone requiring clinical correlation:

   • Given your normal left atrial volume and grade 1 diastolic dysfunction, this likely represents your rising E/e' trend without established HFpEF syndrome 1, 3
   • Consider cardiopulmonary exercise testing with invasive hemodynamics if symptoms worsen, to document whether filling pressures rise with exertion 1
   • Optimize blood pressure control and manage cardiovascular risk factors 1
   • Repeat NT-proBNP in 6–12 months to track progression 2, 6

3. >900 pg/mL: HFpEF syndrome likely present:

   • Initiate loop diuretics for volume management 1, 2
   • Optimize blood pressure control (target <130/80 mmHg) 1
   • Consider SGLT2 inhibitor therapy (emerging evidence in HFpEF) 1
   • Arrange follow-up with heart failure specialist 1

Common Pitfalls to Avoid

• Do not dismiss mildly elevated NT-proBNP (300–900 pg/mL) in the setting of obesity—even modest elevations warrant thorough evaluation, as obesity suppresses natriuretic peptide levels 2, 4
• Do not assume your edema is cardiac just because you have diastolic dysfunction—your normal left atrial volume strongly argues against chronic heart failure 1
• Do not use NT-proBNP alone to make treatment decisions—integrate it with your echocardiographic findings, symptoms, and clinical context 1, 2, 7
• Do not overlook that your rising E/e' trend warrants serial monitoring regardless of current NT-proBNP, as this may signal progression from physiology to syndrome 1, 6